Comment on: Impact of telehealth visits on hydroxyurea response in sickle cell anemia

Pediatr Blood Cancer. 2023 May;70(5):e30207. doi: 10.1002/pbc.30207. Epub 2023 Jan 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents / therapeutic use
  • Humans
  • Hydroxyurea / therapeutic use
  • Telemedicine*

Substances

  • Hydroxyurea
  • Antisickling Agents